Biocardia to host 2022 financial results and corporate update conference call on march 29, 2023

Sunnyvale, calif., march 16, 2023 (globe newswire) -- biocardia®, inc. [nasdaq:bcda], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will report its financial results for the year ended december 31, 2022 and provide a corporate update conference call on wednesday, march 29, 2023 at 4:30 pm et. following management's formal remarks, there will be a question-and-answer session.
BCDA Ratings Summary
BCDA Quant Ranking